Company Filing History:
Years Active: 2015-2018
Title: Innovations by Lionel Gerentes in Hyperbaric Technology
Introduction
Lionel Gerentes is a notable inventor based in Lyons, France. He has made significant contributions to the field of biotechnology, particularly in the development of hyperbaric devices and methods for vaccine production. With a total of 2 patents, his work focuses on enhancing the safety and efficacy of vaccines and therapeutic proteins.
Latest Patents
Gerentes' latest patents include a hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins. This invention relates to hyperbaric devices designed to inactivate microorganisms and viruses while preserving their immunogenicity. It also addresses the production of soluble, disaggregated, refolded, or active immunogenic or therapeutic proteins from inclusion bodies derived from prokaryotes or eukaryotes. The methods encompass hyperbaric techniques for inactivating pathogenic organisms and producing vaccine compositions using these inactivated pathogens. Notably, the hyperbarically inactivated microorganisms are found to be safer and more immunogenic than their chemically inactivated counterparts. Additionally, the solubilized proteins exhibit superior properties compared to more heavily aggregated proteins, including reduced non-specific immune reactions.
Career Highlights
Throughout his career, Gerentes has worked with prominent companies such as Merial Limited and Top Industrie S.a.s. His experience in these organizations has contributed to his expertise in the field of biotechnology and innovation.
Collaborations
Some of his notable coworkers include Nicolas Pierre Yves Carboulec and Rene Labatut. Their collaboration has likely played a role in advancing the projects and innovations that Gerentes has been involved in.
Conclusion
Lionel Gerentes stands out as an influential inventor in the realm of hyperbaric technology and vaccine development. His innovative patents reflect a commitment to improving public health through safer and more effective medical solutions.